|1|Ductal carcinoma in situ of the breast: can biomarkers improve current management? (24262106)
Bartlett J.M.... Rakovitch E.
|2|Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. (23208501)
Pandey P.R.... Watabe K.
|3|Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. (24025166)
Casbas-Hernandez P.... Troester M.A.
|4|Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ. (23381603)
RA-go M.J.... BeltrALo E.I.
|5|Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. (23036368)
Currie M.J.... Robinson B.A.
|6|Comparison of two breast carcinomas: ductal carcinoma in situ and lobular carcinoma in situ. (24147320)
|7|Ductal carcinoma inA situ arising in tubular adenoma of the breast. (22700460)
Saimura M.... Toyoshima S.
|8|The evaluation of the immunoexpression of Her2A^neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast. (23188444)
Fota G.L.... Ciurea R.N.
|9|Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. (22751464)
Lee S.... Allred D.C.
|10|Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast. (21455667)
Banys M.... Fehm T.
|11|Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. (21493791)
Brennan M.E.... Houssami N.
|12|Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. (21547576)
Moelans C.B.... van Diest P.J.
|13|Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. (21710692)
Moelans C.B.... van Diest P.J.
|14|Grading ductal carcinoma in situ of the breast using an automated proliferation index. (21844569)
Stasik C.J.... Tawfik O.W.
|15|Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ. (21522008)
|16|A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy. (22295212)
Sarode V.R.... Rao R.
|17|A rare case of male breast ductal carcinoma in-situ associated with prolactinoma. (22679041)
Mallawaarachchi C.M.... Sinnett D.
|18|Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases. (20236292)
Kawasaki T.... Katoh R.
|19|Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report. (22933920)
Zebic-Sinkovec M.... Snoj M.
|20|Gene amplification in ductal carcinoma in situ of the breast. (20033484)
Burkhardt L.... Lebeau A.
|21|Alcohol consumption and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. (20647412)
Kabat G.C.... Rohan T.E.
|22|PIK3CA mutations in in situ and invasive breast carcinomas. (20551053)
Miron A.... Polyak K.
|23|Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast. (19790246)
Facina G.... da Silva B.B.
|24|Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. (20105298)
Tada K.... Iwase T.
|25|Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. (20634005)
Xie F.... Zhang X.
|26|Ductal carcinoma in situ of the breast treated with accelerated partial breast irradiation using balloon-based brachytherapy. (20443148)
Israel P.Z.... Lyden M.
|27|Ductal carcinoma in situ of the breast. Long-term follow-up of health-related quality of life, emotional reactions and body image. (20598492)
Sackey H.... Brandberg Y.
|28|Comparison of chromogenic in situ hybridisation with fluorescence in situ hybridisation and immunohistochemistry for the assessment of her-2/neu oncogene in archival material of breast carcinoma. (18636112)
Pothos A.... Angelopoulou R.
|29|Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma: Prognostic relevance. (17056098)
PeirA^ G.... SeguA- J.
|30|EGFR gene copy number heterogeneity in fine-needle aspiration cytology from breast carcinomas determined by chromogenic in situ hybridization. (16138375)
Sauer T.... Naess O.
|31|Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation. (15528970)
Thomassen M.... Gerdes A.M.
|32|Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. (15564794)
Lightfoot H.M.... Cance W.G.
|33|Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast. (14534730)
Schmid B.C.... Zeillinger R.
|34|A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. (14534873)
Choi D.H.... Haffty B.G.
|35|Lifetime recreational exercise activity and risk of breast carcinoma in situ. (14601085)
Patel A.V.... Bernstein L.
|36|Collagenous spherulosis of the breast in association with in situ carcinoma. (12540997)
PesutiA8-Pisac V.... TomiA8 S.
|37|p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. (12461063)
Reis-Filho J.S.... Schmitt F.C.
|38|Effect of fixation period on HER2/neu gene amplification detected by fluorescence in situ hybridization in invasive breast carcinoma. (12486093)
Selvarajan S.... Tan P.H.
|39|p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. (11333292)
Done S.J.... Andrulis I.L.
|40|Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. (11685554)
De Paepe B.... Bullock G.R.
|41|Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma. (11466818)
McKee G.T.... Finkelstein D.
|42|Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. (10652623)
Zolota V.... Scopa C.D.
|43|p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. (9071897)
Rudas M.... Reiner A.
|44|Prognostic significance of in situ carcinoma associated with invasive breast carcinoma: a natural experiment in cancer immunology? (9129007)
Naresh K.N.... Borges A.M.
|45|c-erbB-3 protein expression in ductal carcinoma in situ of the breast. (9470844)
Bobrow L.G.... Gullick W.J.
|46|Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. (9006344)
Chuaqui R.F.... Merino M.J.
|47|High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. (8968105)
Man S.... Brook J.D.
|48|TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast. (8944328)
Chitemerere M.... Nesland J.M.
|49|Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. (8100443)
Poller D.N.... Ellis I.O.
|50|An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. (1384227)
BAPcker W.... Schmid K.W.